At 9:30 a.m., Sept. 9, Shenzhen MGI Tech Co. Ltd. (referred to as MGI) made its initial public offering of A shares and was listed on the science and technology innovation board at the Shanghai Stock Exchange (stock symbol: MGI stock, code: 688114). It became the first local Yantian public company of high-end medical devices to be listed.

As a local technology-driven enterprise in Yantian, MGI was established in 2016 with the vision of “Leading Life Science Innovation,” focusing on life science and biotechnology. Its main business covers the research, production and sales of instruments, reagents and consumables and other related products. It also provides real-time, full-scenario, whole-lifecycle digital devices and systems for industries such as precision medicine, precision agriculture and precision health.

MGI is one of the few companies in the world with the ability to independently develop and mass-produce clinical-grade high-throughput gene sequencing machines.